Catalent Inc to Acquire Gene Therapy Leader Paragon Bioservices Inc - M&A Call Transcript
Good morning, ladies and gentlemen, and welcome to the Catalent Investor Call. (Operator Instructions) As a reminder, this call may be recorded.
I would now like to introduce your host for today's conference, Mr. Thomas Castellano, Vice President Investor Relation, Treasurer. You may begin.
Thank you, operator. Good morning, everyone, and thank you for joining us today to discuss Catalent's agreement to acquire Paragon Bioservices, which we announced earlier today.
Joining me today is John Chiminski, Chairman and Chief Executive Officer of Catalent will take us through our prepared remarks; and Wetteny Joseph, Chief Financial Officer.
You'll find a brief slide presentation in the Investor's section of our website catalent.com, and we'll walk you through that deck this morning.
Before we begin, I'd like to draw your attention to the forward-looking statements and additional legal information, which are available at the beginning of the presentation.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |